The Impact of Intraoperative Vasopressor Use and Fluid Status on Flap Survival in Traumatic Lower Extremity Reconstruction

Abstract

Background Historically, the use of intraoperative vasopressors during free flap lower extremity (LE) reconstruction has been proposed to adversely affect flap survival due to concerns about compromising flap perfusion. This study aims to analyze the impact of intraoperative vasopressor use and fluid administration on postoperative outcomes in patients undergoing traumatic LE reconstruction.

Methods Patients who underwent LE free flap reconstruction between 2015 and 2023 at a Level I Trauma Center were retrospectively reviewed. Statistical analysis was conducted to evaluate the association between vasopressor use and intraoperative fluids with partial/complete flap necrosis, as well as the differential effect of vasopressor use on flap outcomes based on varying fluid levels.

Results A total of 105 LE flaps were performed over 8 years. Vasopressors were administered intraoperatively to 19 (18.0%) cases. Overall flap survival and limb salvage rates were 97.1 and 93.3%, respectively. Intraoperative vasopressor use decreased the overall risk of postoperative flap necrosis (OR 0.00005, 95% CI [9.11 × 10⁻⁹–0.285], p = 0.025), while a lower net fluid balance increased the risk of this outcome (OR 0.9985, 95% CI [0.9975–0.9996], p = 0.007). Further interaction analysis revealed that vasopressor use increased the risk of flap necrosis in settings with a higher net fluid balance (OR 1.0032, 95% CI [1.0008–1.0056], p-interaction =0.010).

Conclusion This study demonstrated that intraoperative vasopressor use and adequate fluid status may be beneficial in improving flap outcomes in LE reconstruction. Vasopressor use with adequate fluid management can optimize hemodynamic stability when necessary during traumatic LE microvascular reconstruction without concern for increased risk of flap ischemia.

Keywords

lower extremity - free flap - vasopressor - intraoperative fluids

Note

This study was presented at (1) the American Society of Plastic Surgeons 92nd Annual Meeting; (2) the American Society of Reconstructive Microsurgery 2024 Annual Meeting; and (3) the Southern California Chapter, American College of Surgeons 2023 Annual Scientific Meeting.

Publikationsverlauf

Eingereicht: 04. März 2024

Angenommen: 22. Mai 2024

Accepted Manuscript online:
23. Mai 2024

Artikel online veröffentlicht:
24. Juni 2024

• References

• 1 Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KGM, Kalkman CJ. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 2007; 107 (02) 213-220
• 2 Kelly DA, Reynolds M, Crantford C, Pestana IA. Impact of intraoperative vasopressor use in free tissue transfer for head, neck, and extremity reconstruction. Ann Plast Surg 2014; 72 (06) S135-S138
• 3 Comfere T, Sprung J, Kumar MM. et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005; 100 (03) 636-644
• 4 Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg 2005; 100 (01) 4-10
• 5 Reich DL, Bodian CA, Krol M, Kuroda M, Osinski T, Thys DM. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 1999; 89 (04) 814-822
• 6 Scholz A, Pugh S, Fardy M, Shafik M, Hall JE. The effect of dobutamine on blood flow of free tissue transfer flaps during head and neck reconstructive surgery. Anaesthesia 2009; 64 (10) 1089-1093
• 7 Eley KA, Young JD, Watt-Smith SR. Epinephrine, norepinephrine, dobutamine, and dopexamine effects on free flap skin blood flow. Plast Reconstr Surg 2012; 130 (03) 564-570
• 8 Pattani KM, Byrne P, Boahene K, Richmon J. What makes a good flap go bad? A critical analysis of the literature of intraoperative factors related to free flap failure. Laryngoscope 2010; 120 (04) 717-723
• 9 Chen C, Nguyen M-D, Bar-Meir E. et al. Effects of vasopressor administration on the outcomes of microsurgical breast reconstruction. Ann Plast Surg 2010; 65 (01) 28-31
• 10 Goh CSL, Ng MJM, Song DH, Ooi ASH. Perioperative vasopressor use in free flap surgery: a systematic review and meta-analysis. J Reconstr Microsurg 2019; 35 (07) 529-540
• 11 Ibrahim AMS, Kim PS, Rabie AN, Lee BT, Lin SJ. Vasopressors and reconstructive flap perfusion: a review of the literature comparing the effects of various pharmacologic agents. Ann Plast Surg 2014; 73 (02) 245-248
• 12 Heine-Geldern A, Broer PN, Prantl L. et al. Impact of intraoperative use of vasopressors in lower extremity reconstruction: single centre analysis of 437 free gracilis muscle and fasciocutaneous anterolateral thigh flaps. Clin Hemorheol Microcirc 2019; 71 (02) 193-201
• 13 Hahn HM, Kim TW, Thai DQ, Lee IJ. Impact of perioperative vasopressors on lower extremity free flap reconstruction. Microsurgery 2022; 42 (05) 470-479
• 14 Taylor RJ, Patel R, Wolf BJ. et al. Intraoperative vasopressors in head and neck free flap reconstruction. Microsurgery 2021; 41 (01) 5-13
• 15 Swanson EW, Cheng H-T, Susarla SM. et al. Intraoperative use of vasopressors is safe in head and neck free tissue transfer. J Reconstr Microsurg 2016; 32 (02) 87-93
• 16 Szabo Eltorai A, Huang C-C, Lu JT, Ogura A, Caterson SA, Orgill DP. Selective intraoperative vasopressor use is not associated with increased risk of DIEP flap complications. Plast Reconstr Surg 2017; 140 (01) 70e-77e
• 17 Munro SP, Chang C, Tinker RJ. et al. Intraoperative vasopressor usage in free tissue transfer: should we be worried?. J Reconstr Microsurg 2022; 38 (01) 75-83
• 18 Fang L, Liu J, Yu C, Hanasono MM, Zheng G, Yu P. Intraoperative use of vasopressors does not increase the risk of free flap compromise and failure in cancer patients. Ann Surg 2018; 268 (02) 379-384
• 19 Ruccia F, Savage JA, Sorooshian P, Lees M, Fesatidou V, Zoccali G. Hyponatremia after autologous breast reconstruction: a cohort study comparing two fluid management protocols. J Reconstr Microsurg 2023; 39 (01) 35-42
• 20 Anker AM, Prantl L, Strauss C. et al. Vasopressor support vs. liberal fluid administration in deep inferior epigastric perforator (DIEP) free flap breast reconstruction - a randomized controlled trial. Clin Hemorheol Microcirc 2018; 69 (1-2): 37-44
• 21 Al Saied G, Almutairi HM, Alharbi Y, Almohanna M, Almutairi A. Comparison between the impact of vasopressors and goal-directed fluid therapy on the management of free flap reconstruction of head and neck and monitoring in ICU. Cureus 2020; 12 (12) e12108
• 22 Karamanos E, Walker R, Wang HT, Shah AR. Perioperative fluid resuscitation in free flap breast reconstruction: when is enough enough?. Plast Reconstr Surg Glob Open 2020; 8 (03) e2662
• 23 Naik AN, Freeman T, Li MM. et al. The use of vasopressor agents in free tissue transfer for head and neck reconstruction: current trends and review of the literature. Front Pharmacol 2020; 11: 1248
• 24 Russell JA. Vasopressor therapy in critically ill patients with shock. Intensive Care Med 2019; 45 (11) 1503-1517
• 25 Thiele RH, Nemergut EC, Lynch III C. The clinical implications of isolated alpha(1) adrenergic stimulation. Anesth Analg 2011; 113 (02) 297-304
• 26 Meng L, Cannesson M, Alexander BS. et al. Effect of phenylephrine and ephedrine bolus treatment on cerebral oxygenation in anaesthetized patients. Br J Anaesth 2011; 107 (02) 209-217
• 27 Michelle L, Bitner BF, Pang JC. et al. Outcomes of perioperative vasopressor use for hemodynamic management of patients undergoing free flap surgery: a systematic review and meta-analysis. Head Neck 2023; 45 (03) 721-732